Detecting Leishmania in dogs: A hierarchical-modeling approach to investigate the performance of parasitological and qPCR-based diagnostic procedures.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
13
08
2022
accepted:
08
12
2022
revised:
30
12
2022
pubmed:
17
12
2022
medline:
4
1
2023
entrez:
16
12
2022
Statut:
epublish
Résumé
Domestic dogs are primary reservoir hosts of Leishmania infantum, the agent of visceral leishmaniasis. Detecting dog infections is central to epidemiological inference, disease prevention, and veterinary practice. Error-free diagnostic procedures, however, are lacking, and the performance of those available is difficult to measure in the absence of fail-safe "reference standards". Here, we illustrate how a hierarchical-modeling approach can be used to formally account for false-negative and false-positive results when investigating the process of Leishmania detection in dogs. We studied 294 field-sampled dogs of unknown infection status from a Leishmania-endemic region. We ran 350 parasitological tests (bone-marrow microscopy and culture) and 1,016 qPCR assays (blood, bone-marrow, and eye-swab samples with amplifiable DNA). Using replicate test results and site-occupancy models, we estimated (a) clinical sensitivity for each diagnostic procedure and (b) clinical specificity for qPCRs; parasitological tests were assumed 100% specific. Initial modeling revealed qPCR specificity < 94%; we tracked the source of this unexpected result to some qPCR plates having subtle signs of possible contamination. Using multi-model inference, we formally accounted for suspected plate contamination and estimated qPCR sensitivity at 49-53% across sample types and dog clinical conditions; qPCR specificity was high (95-96%), but fell to 81-82% for assays run in plates with suspected contamination. The sensitivity of parasitological procedures was low (~12-13%), but increased to ~33% (with substantial uncertainty) for bone-marrow culture in seriously-diseased dogs. Leishmania-infection frequency estimates (~49-50% across clinical conditions) were lower than observed (~60%). We provide statistical estimates of key performance parameters for five diagnostic procedures used to detect Leishmania in dogs. Low clinical sensitivies likely reflect the absence of Leishmania parasites/DNA in perhaps ~50-70% of samples drawn from infected dogs. Although qPCR performance was similar across sample types, non-invasive eye-swabs were overall less likely to contain amplifiable DNA. Finally, modeling was instrumental to discovering (and formally accounting for) possible qPCR-plate contamination; even with stringent negative/blank-control scoring, ~4-5% of positive qPCRs were most likely false-positives. This work shows, in sum, how hierarchical site-occupancy models can sharpen our understanding of the problem of diagnosing host infections with hard-to-detect pathogens including Leishmania.
Sections du résumé
BACKGROUND
Domestic dogs are primary reservoir hosts of Leishmania infantum, the agent of visceral leishmaniasis. Detecting dog infections is central to epidemiological inference, disease prevention, and veterinary practice. Error-free diagnostic procedures, however, are lacking, and the performance of those available is difficult to measure in the absence of fail-safe "reference standards". Here, we illustrate how a hierarchical-modeling approach can be used to formally account for false-negative and false-positive results when investigating the process of Leishmania detection in dogs.
METHODS/FINDINGS
We studied 294 field-sampled dogs of unknown infection status from a Leishmania-endemic region. We ran 350 parasitological tests (bone-marrow microscopy and culture) and 1,016 qPCR assays (blood, bone-marrow, and eye-swab samples with amplifiable DNA). Using replicate test results and site-occupancy models, we estimated (a) clinical sensitivity for each diagnostic procedure and (b) clinical specificity for qPCRs; parasitological tests were assumed 100% specific. Initial modeling revealed qPCR specificity < 94%; we tracked the source of this unexpected result to some qPCR plates having subtle signs of possible contamination. Using multi-model inference, we formally accounted for suspected plate contamination and estimated qPCR sensitivity at 49-53% across sample types and dog clinical conditions; qPCR specificity was high (95-96%), but fell to 81-82% for assays run in plates with suspected contamination. The sensitivity of parasitological procedures was low (~12-13%), but increased to ~33% (with substantial uncertainty) for bone-marrow culture in seriously-diseased dogs. Leishmania-infection frequency estimates (~49-50% across clinical conditions) were lower than observed (~60%).
CONCLUSIONS
We provide statistical estimates of key performance parameters for five diagnostic procedures used to detect Leishmania in dogs. Low clinical sensitivies likely reflect the absence of Leishmania parasites/DNA in perhaps ~50-70% of samples drawn from infected dogs. Although qPCR performance was similar across sample types, non-invasive eye-swabs were overall less likely to contain amplifiable DNA. Finally, modeling was instrumental to discovering (and formally accounting for) possible qPCR-plate contamination; even with stringent negative/blank-control scoring, ~4-5% of positive qPCRs were most likely false-positives. This work shows, in sum, how hierarchical site-occupancy models can sharpen our understanding of the problem of diagnosing host infections with hard-to-detect pathogens including Leishmania.
Identifiants
pubmed: 36525465
doi: 10.1371/journal.pntd.0011011
pii: PNTD-D-22-01042
pmc: PMC9803295
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011011Informations de copyright
Copyright: © 2022 Vital et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2019 Jul 5;14(7):e0219395
pubmed: 31276573
J Clin Microbiol. 2017 Feb;55(2):526-534
pubmed: 27927916
Parasit Vectors. 2014 Mar 24;7:111
pubmed: 24655335
Vet Parasitol. 2022 Jan;301:109638
pubmed: 34920304
Vet Parasitol. 2009 Oct 28;165(1-2):1-18
pubmed: 19559536
Vet Clin Pathol. 2016 Dec;45(4):552-578
pubmed: 27805725
Parasit Vectors. 2011 Apr 13;4:57
pubmed: 21489253
Exp Parasitol. 2019 Dec;207:107773
pubmed: 31605671
BMC Bioinformatics. 2011 Jan 26;12:35
pubmed: 21269502
Front Microbiol. 2017 Oct 04;8:1907
pubmed: 29046670
PLoS Negl Trop Dis. 2013;7(1):e1956
pubmed: 23301111
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008751
pubmed: 33120404
PLoS One. 2021 Aug 31;16(8):e0256534
pubmed: 34464421
Res Vet Sci. 2019 Apr;123:261-272
pubmed: 30708238
J Clin Microbiol. 2014 Sep;52(9):3147-55
pubmed: 24829226
Epidemiol Infect. 1999 Dec;123(3):499-506
pubmed: 10694163
Trends Parasitol. 2017 Sep;33(9):706-717
pubmed: 28689776
PLoS Negl Trop Dis. 2016 Jan 05;10(1):e0004333
pubmed: 26731098
J Clin Invest. 1994 Sep;94(3):1226-34
pubmed: 8083364
Comp Immunol Microbiol Infect Dis. 2020 Dec;73:101542
pubmed: 32942122
PLoS Negl Trop Dis. 2021 Jul 19;15(7):e0009552
pubmed: 34280201
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):289-99
pubmed: 15015033
Parasit Vectors. 2011 May 20;4:86
pubmed: 21599936
Adv Parasitol. 2004;57:1-88
pubmed: 15504537
PLoS Negl Trop Dis. 2012;6(4):e1596
pubmed: 22506084
Nat Rev Microbiol. 2007 Nov;5(11):873-82
pubmed: 17938629
PLoS One. 2013;8(4):e60535
pubmed: 23577121
Ecology. 2006 Apr;87(4):835-41
pubmed: 16676527
Sci Rep. 2018 Jan 9;8(1):151
pubmed: 29317702
Microorganisms. 2021 Dec 20;9(12):
pubmed: 34946227
Prev Vet Med. 2017 Oct 1;146:10-15
pubmed: 28992913
J Infect Dis. 2004 May 1;189(9):1729-33
pubmed: 15116312
Ecohealth. 2017 Mar;14(Suppl 1):156-166
pubmed: 26769428
Vet Parasitol. 2012 Feb 28;184(1):10-7
pubmed: 21906883
Sci Rep. 2017 Nov 21;7(1):15914
pubmed: 29162847
Expert Rev Mol Diagn. 2017 Jul;17(7):699-710
pubmed: 28582629
Pathogens. 2021 Jul 09;10(7):
pubmed: 34358015
Am J Trop Med Hyg. 2010 Feb;82(2):251-6
pubmed: 20134001
Ecol Lett. 2010 Jun;13(6):659-74
pubmed: 20426794
Mol Ecol Resour. 2018 May;18(3):580-589
pubmed: 29418078
PLoS Negl Trop Dis. 2013;7(1):e2000
pubmed: 23350002
Mem Inst Oswaldo Cruz. 2020 Apr 27;115:e190349
pubmed: 32348406
J Clin Microbiol. 2001 Feb;39(2):560-3
pubmed: 11158106
Trop Med Int Health. 2015 Mar;20(3):334-52
pubmed: 25403359
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006082
pubmed: 29324838
Mem Inst Oswaldo Cruz. 2019 Jan 31;114:e180452
pubmed: 30726343
Mol Ecol Resour. 2018 Mar;18(2):368-380
pubmed: 29120090
PLoS One. 2014 Jul 30;9(7):e103635
pubmed: 25076494
PLoS Negl Trop Dis. 2022 Aug 4;16(8):e0010612
pubmed: 35925882
Mem Inst Oswaldo Cruz. 1999 Jul-Aug;94(4):505-8
pubmed: 10446010
Ecology. 2011 Jul;92(7):1422-8
pubmed: 21870616
PLoS Negl Trop Dis. 2011 Aug;5(8):e1291
pubmed: 21858243
Anal Bioanal Chem. 2020 Apr;412(9):2009-2023
pubmed: 32052066
Biomed Res Int. 2014;2014:412808
pubmed: 24995294
J Clin Microbiol. 2013 Jun;51(6):1826-33
pubmed: 23554201
Parasit Vectors. 2012 Jan 12;5:15
pubmed: 22240199
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Trends Parasitol. 2018 Oct;34(10):881-890
pubmed: 30131210